362 related articles for article (PubMed ID: 21245374)
1. Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.
Ellis JM; Mentock SM; Depetrillo MA; Koves TR; Sen S; Watkins SM; Muoio DM; Cline GW; Taegtmeyer H; Shulman GI; Willis MS; Coleman RA
Mol Cell Biol; 2011 Mar; 31(6):1252-62. PubMed ID: 21245374
[TBL] [Abstract][Full Text] [Related]
2. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin.
Paul DS; Grevengoed TJ; Pascual F; Ellis JM; Willis MS; Coleman RA
Biochim Biophys Acta; 2014 Jun; 1841(6):880-7. PubMed ID: 24631848
[TBL] [Abstract][Full Text] [Related]
4. Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin.
Schisler JC; Grevengoed TJ; Pascual F; Cooper DE; Ellis JM; Paul DS; Willis MS; Patterson C; Jia W; Coleman RA
J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713290
[TBL] [Abstract][Full Text] [Related]
5. Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.
Grevengoed TJ; Cooper DE; Young PA; Ellis JM; Coleman RA
FASEB J; 2015 Nov; 29(11):4641-53. PubMed ID: 26220174
[TBL] [Abstract][Full Text] [Related]
6. Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.
Zhao L; Pascual F; Bacudio L; Suchanek AL; Young PA; Li LO; Martin SA; Camporez JP; Perry RJ; Shulman GI; Klett EL; Coleman RA
J Biol Chem; 2019 May; 294(22):8819-8833. PubMed ID: 30975900
[TBL] [Abstract][Full Text] [Related]
7. Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.
Goldenberg JR; Wang X; Lewandowski ED
J Mol Cell Cardiol; 2016 May; 94():1-9. PubMed ID: 26995156
[TBL] [Abstract][Full Text] [Related]
8. Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function.
Grevengoed TJ; Martin SA; Katunga L; Cooper DE; Anderson EJ; Murphy RC; Coleman RA
J Lipid Res; 2015 Aug; 56(8):1572-82. PubMed ID: 26136511
[TBL] [Abstract][Full Text] [Related]
9. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition.
Li LO; Ellis JM; Paich HA; Wang S; Gong N; Altshuller G; Thresher RJ; Koves TR; Watkins SM; Muoio DM; Cline GW; Shulman GI; Coleman RA
J Biol Chem; 2009 Oct; 284(41):27816-27826. PubMed ID: 19648649
[TBL] [Abstract][Full Text] [Related]
10. Adipose acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis.
Ellis JM; Li LO; Wu PC; Koves TR; Ilkayeva O; Stevens RD; Watkins SM; Muoio DM; Coleman RA
Cell Metab; 2010 Jul; 12(1):53-64. PubMed ID: 20620995
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalized acyl-CoA metabolism in skeletal muscle regulates systemic glucose homeostasis.
Li LO; Grevengoed TJ; Paul DS; Ilkayeva O; Koves TR; Pascual F; Newgard CB; Muoio DM; Coleman RA
Diabetes; 2015 Jan; 64(1):23-35. PubMed ID: 25071025
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo.
Parkes HA; Preston E; Wilks D; Ballesteros M; Carpenter L; Wood L; Kraegen EW; Furler SM; Cooney GJ
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E737-44. PubMed ID: 16705061
[TBL] [Abstract][Full Text] [Related]
13. Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart.
de Jong H; Neal AC; Coleman RA; Lewin TM
Biochim Biophys Acta; 2007 Jan; 1771(1):75-82. PubMed ID: 17197235
[TBL] [Abstract][Full Text] [Related]
14. Modeling the Transition From Decompensated to Pathological Hypertrophy.
Pascual F; Schisler JC; Grevengoed TJ; Willis MS; Coleman RA
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29622588
[TBL] [Abstract][Full Text] [Related]
15. TANK-Binding Kinase 1 Regulates the Localization of Acyl-CoA Synthetase ACSL1 to Control Hepatic Fatty Acid Oxidation.
Huh JY; Reilly SM; Abu-Odeh M; Murphy AN; Mahata SK; Zhang J; Cho Y; Seo JB; Hung CW; Green CR; Metallo CM; Saltiel AR
Cell Metab; 2020 Dec; 32(6):1012-1027.e7. PubMed ID: 33152322
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of long-chain acyl-CoA synthetase 1 in 3T3-L1 adipocytes.
Lobo S; Wiczer BM; Bernlohr DA
J Biol Chem; 2009 Jul; 284(27):18347-56. PubMed ID: 19429676
[TBL] [Abstract][Full Text] [Related]
17. Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways.
Young PA; Senkal CE; Suchanek AL; Grevengoed TJ; Lin DD; Zhao L; Crunk AE; Klett EL; Füllekrug J; Obeid LM; Coleman RA
J Biol Chem; 2018 Oct; 293(43):16724-16740. PubMed ID: 30190326
[TBL] [Abstract][Full Text] [Related]
18. Fatty acids and inflammatory stimuli induce expression of long-chain acyl-CoA synthetase 1 to promote lipid remodeling in diabetic kidney disease.
Wang CH; Surbhi ; Goraya S; Byun J; Pennathur S
J Biol Chem; 2024 Jan; 300(1):105502. PubMed ID: 38016515
[TBL] [Abstract][Full Text] [Related]
19. Long-chain acyl-CoA synthetase 6 regulates lipid synthesis and mitochondrial oxidative capacity in human and rat skeletal muscle.
Teodoro BG; Sampaio IH; Bomfim LH; Queiroz AL; Silveira LR; Souza AO; Fernandes AM; Eberlin MN; Huang TY; Zheng D; Neufer PD; Cortright RN; Alberici LC
J Physiol; 2017 Feb; 595(3):677-693. PubMed ID: 27647415
[TBL] [Abstract][Full Text] [Related]
20. Endothelial acyl-CoA synthetase 1 is not required for inflammatory and apoptotic effects of a saturated fatty acid-rich environment.
Li X; Gonzalez O; Shen X; Barnhart S; Kramer F; Kanter JE; Vivekanandan-Giri A; Tsuchiya K; Handa P; Pennathur S; Kim F; Coleman RA; Schaffer JE; Bornfeldt KE
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):232-40. PubMed ID: 23241406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
